Radiological and Clinical Efficacy of Intra-Arterial <sup>90</sup>Y-DOTATATE in Patients with Unresectable, Progressive, Liver Dominant Neuroendocrine Neoplasms
This study was performed to determine if intra-arterial (i.a.) administration of <sup>90</sup>Y DOTATATE can provide an effective and safe alternative to the accepted standard for i.v. of peptide receptor radionuclide therapy (PRRT) in liver-dominant metastases of gastrointestinal pancre...
Main Authors: | Agnieszka Kolasińska-Ćwikła, Mirosław L. Nowicki, Artur J. Sankowski, Jakub M. Pałucki, John R. Buscombe, Lidia Glinka, Jarosław B. Ćwikła |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/8/1794 |
Similar Items
-
<sup>177</sup>Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials
by: Alberto Bongiovanni, et al.
Published: (2022-12-01) -
Peptide Receptor Radionuclide Therapy (PRRT) with <sup>177</sup>Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms
by: Ulrika Jahn, et al.
Published: (2021-02-01) -
Prediction of <sup>177</sup>Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on <sup>68</sup>Ga-DOTATATE PET/CT
by: Hwan Lee, et al.
Published: (2023-12-01) -
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with <sup>177</sup>Lu-DOTATATE
by: Achyut Ram Vyakaranam, et al.
Published: (2019-06-01) -
Lutathera<sup>®</sup> Orphans: State of the Art and Future Application of Radioligand Therapy with <sup>177</sup>Lu-DOTATATE
by: Luca Urso, et al.
Published: (2023-03-01)